While national security experts have frequently warned about U.S. dependence on Chinese rare-earth metals, which are essential components in many high-technology military and commercial products, the pharmaceutical ingredient supply chain is far less understood — though potentially every bit as dire. Why? Because, as Rosemary Gibson, a senior adviser at The Hastings Center, recently testified: “If China shut the door on exports of medicines and their key ingredients and raw material, U.S. hospitals and military hospitals and clinics would cease to function within months, if not days.” Read more in the Washington Post.